Skip to content

What happens to people who become HIV positive in prevention trials?

Microbicides: the quest for user-friendly formulations

Treatment and PrEP could be on a ‘collision course’, warns resistance expert

Microbicides could increase HIV infections in certain circumstances, models predict

Adherence to ARV prevention methods is challenging, partly because they don’t treat illness

Once-a-day treatment: the consequences of poor adherence may be more serious

Rectal lubricants may enhance the risk of STIs

Initial surveys of MSM in Nigeria show high levels of bisexual behaviour and low condom and lube use

Crunch time for microbicides, says top researcher